To Assess the Safety and Efficacy of R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Public ClinicalTrials.gov record NCT01900249. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multi-Center, Randomized, Double-Masked, Placebo-Controlled Clinical Study to Assess the Safety and Efficacy of 0.2% and 0.5% R932348 Ophthalmic Solutions in Patients With Keratoconjunctivitis Sicca
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether 0.2% and 0.5% R348 Ophthalmic Solutions are safe and effective in the treatment of Patients with Keratoconjunctivitis Sicca.
Study identification
- NCT ID
- NCT01900249
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 204 participants
Conditions and interventions
Conditions
Interventions
- R348 Ophthalmic Solution, 0.2% Drug
- R348 Ophthalmic Solution, 0.5% Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2013 (Type not available)
- Primary completion
- Jul 2014 (Actual)
- Completion
- Jul 2014 (Actual)
- Last update posted
- Oct 3, 2016
2013 – 2014
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sall Research Medical Center | Artesia | California | 90701 | — |
| North Bay Eye | Petaluma | California | 94954 | — |
| Martel Medical Eye Group | Rancho Cardova | California | 95670 | — |
| Specialty Eye Care | Parker | Colorado | 808134 | — |
| International Research Center | Brandon | Florida | 33603 | — |
| East Florida Eye Institute | Stuart | Florida | 34994 | — |
| Clayton Eye Center | Morrow | Georgia | 30260 | — |
| Coastal Research Associates | Roswell | Georgia | 30076 | — |
| Chicago Research Center | Chicago | Illinois | 60634 | — |
| Chicago Cornea Consultants | Hoffman Estates | Illinois | 60169 | — |
| Koffler Vision Group | Lebanon | Kentucky | 40033 | — |
| Taustine Eye Center | Louisville | Kentucky | 40217 | — |
| Comprehensive Eye Care, Ltd/Vision Research Institute, LLC | Washington | Missouri | 63090 | — |
| Mundorf Eye Center | Charlotte | North Carolina | 28204 | — |
| Charlotte Eye Ear Nose and Throat Associates, PA | Charlotte | North Carolina | 28210 | — |
| Cornerstone Eyecare | High Point | North Carolina | 27262 | — |
| Abrams Eye Center | Cleveland | Ohio | 44115 | — |
| Glaucoma Consultants and Center for Eye Research | Mt. Pleasant | South Carolina | 29464 | — |
| Chattanooga Eye Institute | Chattanooga | Tennessee | 37411 | — |
| Eye Clinics of South Texas | San Antonio | Texas | 78209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01900249, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 3, 2016 · Synced Nov 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01900249 live on ClinicalTrials.gov.